Mark Wegter
InvestorPartner at EQT Life Sciences
Amsterdam, Netherlands
Writes $2.2M – $54M checks · typically $25M
About
Mark Wegter keeps a low public profile, preferring behind-the-scenes, governance-heavy, board-focused investing rooted in deep experience as a director and a background in traditional European private equity and growth capital.
Invests in
AI & Machine LearningClimate TechFintechSaaSSpace Tech
Deals · 1
Kiadis Pharma N.VBoard seat
via EQT Life Sciences · filed Jun 2019 · $18.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at EQT Life Sciences
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christina Drews
Chief Operating Officer at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences